|
⚲
|
| Keyboard |
| Lavino Francesco Maria
✚
|
|
|---|---|
| CIK # | 0001711517 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001711517] | |
| 4 | [0001711517] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nabriva Therapeutics AG | |
| Lavino Francesco Maria | |
| Nabriva Therapeutics Legacy PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-09-30 | Tax withheld | 366 | $0.53 | 194 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-08-31 | Tax withheld | 366 | $0.62 | 227 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-08-20 | Tax withheld | 3,759 | $0.65 | 2,443 |
|
Nabriva Therapeutics AG NBRV
Restricted Share Units · derivative
|
2020-08-19 | Option exercise | 11,250 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-08-19 | Option exercise | 11,250 | ||
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-07-31 | Tax withheld | 366 | $0.76 | 278 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-06-30 | Tax withheld | 366 | $0.67 | 245 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-05-31 | Tax withheld | 366 | $1.14 | 417 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-04-30 | Tax withheld | 366 | $0.55 | 201 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-03-31 | Tax withheld | 366 | $0.58 | 212 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-02-28 | Tax withheld | 366 | $1.35 | 494 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-02-06 | Grant | 105,000 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Stock Options · derivative
|
2020-02-06 | Grant | 210,000 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-01-31 | Tax withheld | 3,892 | $1.35 | 5,254 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2019-08-22 | Buy | 4,800 | $2.04 | 9,792 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2019-08-21 | Tax withheld | 3,797 | $2.08 | 7,898 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2019-08-19 | Option exercise | 11,250 | ||
|
Nabriva Therapeutics AG NBRV
Restricted Share Units · derivative
|
2019-08-19 | Option exercise | 11,250 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Stock Options · derivative
|
2019-01-31 | Grant | 138,200 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Restricted Stock Units · derivative
|
2019-01-31 | Grant | 52,500 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||